“…For example, pharmacological inhibition of MEK, the upstream activator of the two major ERK isoforms in the brain (ERK1 and ERK2), prevents both hippocampus-and amygdala-dependent memory formation (Atkins et al, 1998;Schafe et al, 1999;Adams and Sweatt, 2002). Pharmacological blockade of the Raf-MEK-ERK cascade also attenuates the development of a conditioned place preference to cocaine, amphetamine or MDMA (Valjent et al, 2000;Salzmann et al, 2003;Gerdjikov et al, 2004) and appears to modulate the development of psychomotor sensitization to cocaine (Pierce et al, 1999;Valjent et al, 2005). In addition, administration of psychomotor stimulant drugs increases ERK activity in several mesocorticolimbic brain regions associated with drug addiction (Valjent et al, 2000(Valjent et al, , 2005Adams et al, 2001; and the induction of immediate early genes (IEGs) in these brain regions is largely attenuated by pharmacological blockade of this pathway (Valjent et al, 2000;Salzmann et al, 2003;Ferguson and Robinson, 2004).…”